The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of drug targeting (Print)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/10611869409015902PMID 8069591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Complements C3 and C5 in the Phagocytosis of Liposomes by Human Neutrophils

  2004cited by this paper
• Distinction Between the Depletion of Opsonins and the Saturation of Uptake in the Dose-Dependent Hepatic Uptake of Liposomes

  1993cited by this paper
• Serum opsonins and liposomes: their interaction and opsonophagocytosis.

  1992cited by this paper
• Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

  1992cited by this paper
• Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor

  1991cited by this paper
• Complement receptors and phagocytosis.

  1991cited by this paper
• Enhancing effect of cetylmannoside on targeting of liposomes to Kupffer cells in rats

  1991cited by this paper
• Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes.

  1990cited by this paper
• Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes

  1990cited by this paper
• The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein.

  1990cited by this paper
• Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages.

  1989cited by this paper
• Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.

  1988cited by this paper
• Mannose-mediated targeted immunoadjuvant action of liposomes.

  1988cited by this paper
• Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastases.

  1987cited by this paper
• Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages.

  1986cited by this paper
• Application of synthetic alkyl glycoside vesicles as drug carriers. I. Preparation and physical properties.

  1985cited by this paper
• Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose.

  1984cited by this paper
• Human serum contains a lectin which inhibits hepatic uptake of glycoproteins

  1984cited by this paper
• Isolation and characterization of a mannan-binding protein from human serum.

  1983cited by this paper
• Yeast Mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages

  1983cited by this paper
• Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling

  1982cited by this paper
• A new complement-dependent bactericidal factor found in nonimmune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella.

  1982cited by this paper
• Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.

  1981cited by this paper
• Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling.

  1980cited by this paper
• Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages.

  1978cited by this paper
• Plasma clearance of glycoproteins with terminal mannose and N-acetylglucosamine by liver non-parenchymal cells. Studies with beta-glucuronidase, N-acetyl-beta-D-glucosaminidase, ribonuclease B and agalacto-orosomucoid.

  1978cited by this paper
• Isolation and characterization of a mannan-binding protein from rabbit serum.

  1978cited by this paper

• Liposome and immune system interplay: Challenges and potentials.

  2019cites this paper
• Nanostructured glycopolymer augmented liposomes to elucidate carbohydrate-mediated targeting.

  2016cites this paper
• Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

  2013cites this paper
• Surface Engineering of Liposomes for Stealth Behavior

  2013cites this paper
• Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.

  2012cites this paper
• Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins

  2007cites this paper
• Multimeric HCV E2 protein obtained from pichia pastoris cells induces a strong immune response in mice

  2007cites this paper
• Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.

  2006cites this paper
• Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein

  2006cites this paper
• Molecular Epidemiology of Hepatitis C Virus Genotype 4 Isolates in Egypt and Analysis of the Variability of Envelope Proteins E1 and E2 in Patients with Chronic Hepatitis

  2005cites this paper
• Liposomal Delivery of Antileishmanial Agents

  2005cites this paper
• The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.

  2005cites this paper
• Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus.

  2004cites this paper
• Novel insights into hepatitis C virus replication and persistence.

  2004cites this paper
• Effect of the 5' non-translated region on self-assembly of hepatitis C virus genotype 1a structural proteins produced in insect cells.

  2004cites this paper
• Efficient preparation of carbohydrate- and related polyol-amphiphiles by hydrazone ligation

  2004cites this paper
• Expression of hepatitis C virus core protein inhibits interferon‐induced nuclear import of STATs

  2004cites this paper
• HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.

  2004cites this paper
• Expression and purification of E2/NS1 protein of hepatitis C virus and detection of anti-E2/NS1 antibodies in chronic liver disease patients.

  2003cites this paper
• Liposome Clearance

  2002cites this paper
• Generation of Hepatitis C Virus-Like Particles by Use of a Recombinant Vesicular Stomatitis Virus Vector

  2002cites this paper
• Analysis of the C-Terminal Membrane Anchor Domains of Hepatitis C Virus Glycoproteins E1 and E2: toward a Topological Model

  2002cites this paper
• Important role of serum proteins associated on the surface of particles in their hepatic disposition.

  2002cites this paper
• Major determinants in hepatic disposition of polystyrene nanospheres: implication for rational design of particulate drug carriers.

  2002cites this paper
• Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats.

  2001cites this paper
• Biliary excretion of polystyrene microspheres depends on the type of receptor-mediated uptake in rat liver.

  2001cites this paper
• Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System

  2001cites this paper
• Species difference in correlation between in vivo/in vitro liposome-complement interactions.

  2001cites this paper
• Multivalency in Protein-Carbohydrate Recognition

  2001cites this paper
• The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.

  2001cites this paper
• Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites

  2001cites this paper
• Interactions of liposomes with cells in vitro and in vivo: opsonins and receptors.

  2001cites this paper
• Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.

  2001cites this paper
• Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome.

  2000cites this paper
• Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship.

  2000cites this paper
• Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection

  2000cites this paper
• Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.

  2000cites this paper
• Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2.

  1999cites this paper
• Mechanisms of hepatic disposition of polystyrene microspheres in rats: effects of serum depend on the sizes of microspheres.

  1999cites this paper
• Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81

  1999cites this paper
• Aging alters properties of the circadian pacemaker controlling the locomotor activity rhythm in males of Drosophila nasuta.

  1999cites this paper
• C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner.

  1999cites this paper
• The Transmembrane Domain of Hepatitis C Virus Glycoprotein E1 Is a Signal for Static Retention in the Endoplasmic Reticulum

  1999cites this paper
• Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats.

  1999cites this paper
• Unusual electrostatic effects on binding of C1q to anionic liposomes: role of anionic phospholipid domains and their line tension.

  1999cites this paper
• Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant.

  1998cites this paper
• Secretion and purification of HCV E1 protein forms as glutathione-S-transferase fusion in the baculovirus insect cell system.

  1998cites this paper
• リポソーム膜中のコレステロール含量が及ぼす補体第3成分(C3)の結合と体内動態への影響

  1998cites this paper
• Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.

  1998cites this paper
• A novel plasma factor initiating complement activation on cetylmannoside-modified liposomes in human plasma

  1998cites this paper
• The interaction of liposomes with the complement system.

  1998cites this paper
• Complement dependent and independent liposome uptake by peritoneal macrophages: cholesterol content dependency.

  1998cites this paper
• Hepatitis C virus envelope DNA-based immunization elicits humoral and cellular immune responses.

  1998cites this paper
• The complement system in liposome clearance: Can complement deposition be inhibited?

  1998cites this paper
• Identification of proteins mediating clearance of liposomes using a liver perfusion system.

  1998cites this paper
• Hepatitis C virus E1 protein induces modification of membrane permeability in E. coli cells.

  1998cites this paper
• Effect of serum components from different species on destabilizing hydrogenated phosphatidylcholine-based liposomes.

  1997cites this paper
• Enhancing effect of cholesterol on the elimination of liposomes from circulation is mediated by complement activation

  1997cites this paper
• Plasma factors affecting disposition of liposomes

  1997cites this paper
• The role of immunoproteins in the survival of liposomes in the circulation.

  1997cites this paper
• Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.

  1996cites this paper
• Strength in numbers: non-natural polyvalent carbohydrate derivatives.

  1996cites this paper
• Modification of liposomes for liver targeting.

  1996cites this paper
• Studies on the Mechanism of Uptake of Liposomes Using An Isolated Perfused Liver System

  1996cites this paper
• Liposomal targeting and drug delivery: kinetic consideration

  1996cites this paper
• Pharmacokinetic Studies on the Drug Delivery System Using Liposomes

  1995cites this paper
• Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.

  1995cites this paper